Position in ABCL
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$46,630,225
+$935,277 QoQ
Shares Held
13,361,096
0.0% QoQ
Ownership
4.38%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#2
of 138 holders
Holding Since
Dec 2020
21 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in ABCL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Capital World Investors holds $23,534,298,325 across 32 Biotechnology names. ABCL ranks #22 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
25,368,124 | $11,327,882,090 | |
| 2 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
10,802,348 | $3,574,172,882 | |
| 3 | ARGX |
Argenx SE
|
2,256,216 | $1,647,601,734 | |
| 4 | IONS |
Ionis Pharmaceuticals Inc
|
21,186,369 | $1,590,884,448 | |
| 5 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,419,000 | $1,096,376,160 | |
| 6 | MRNA |
Moderna, Inc.
|
18,697,694 | $949,842,855 | |
| 7 | JAZZ |
Jazz Pharmaceuticals plc
|
2,673,376 | $505,401,732 | |
| 8 | ONC |
BeOne Medicines Ltd.
|
1,622,687 | $481,889,358 |
All Filings in ABCL
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $46,630,225 | 13,361,096 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $45,694,948 | 13,361,096 | Shares | Defined | 2026-02-11 | |
| 2025-09-30 | $67,206,312 | 13,361,096 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $45,828,559 | 13,361,096 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $29,795,244 | 13,361,096 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $23,245,486 | 7,933,613 | Shares | Defined | 2025-02-13 | |
| 2024-06-30 | $15,743,627 | 5,318,793 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $37,831,357 | 8,351,293 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $47,685,883 | 8,351,293 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $38,734,267 | 8,420,493 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $54,396,384 | 8,420,493 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $70,329,297 | 9,327,493 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $94,487,504 | 9,327,493 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $94,753,706 | 9,580,759 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $138,858,502 | 13,038,357 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $178,110,806 | 18,267,775 | Shares | Defined | 2022-05-19 | |
| 2021-12-31 | $315,339,352 | 22,051,703 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $397,220,996 | 19,821,407 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $295,139,614 | 13,415,437 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $141,303,145 | 4,160,870 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $146,450,381 | 3,639,423 | Shares | Defined | 2021-02-12 | |
| No filing history on record for this holder in this stock. | ||||||